Want to see IN:SHK full AI Analyst Report?
SHK Stock Chart & Stats
₹140.10
₹7.61(5.41%)
At close: 4:00 PM EDT
₹140.10
₹7.61(5.41%)
Day’s Range― - ―
52-Week Range₹111.70 - ₹269.50
Previous CloseN/A
Volume897.53K
Average Volume (3M)63.88K
Market Cap
₹20.97B
Enterprise Value₹25.15K
Total Cash (Recent Filing)₹645.90M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)23.4
Beta1.69
Next Earnings
Nov 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.32%
Share Statistics
EPS (TTM)6.43
Shares Outstanding138,420,800
10 Day Avg. Volume17,368
30 Day Avg. Volume63,875
Financial Highlights & Ratios
PEG Ratio-3.85
Price to Book (P/B)1.14
Price to Sales (P/S)0.66
P/FCF Ratio293.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.4
Revenue Forecast (FY)₹26.59B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSustained revenue growth indicates continued demand for SHK’s fragrance and flavor offerings across its served markets. A larger revenue base can support scale benefits, ongoing customer engagement, and reinvestment in formulation capabilities even while profitability remains under pressure.
Broad End-market ExposureExposure to multiple recurring consumer and industrial applications reduces reliance on any single product category. Fragrances and flavors are embedded in customers’ finished products, which can support repeat B2B orders and provide several avenues for durable demand across domestic and international markets.
Moderate LeverageModerate leverage and a growing equity base provide SHK with a serviceable financial foundation for operating through business cycles. Although debt has risen, the balance sheet is not described as heavily leveraged, preserving more flexibility than a highly indebted structure would allow.
Bears Say
Material Margin CompressionThe sharp decline in gross, operating, and net margins shows that higher revenue is currently producing substantially weaker earnings. If this reset persists, reduced internal profitability could limit reinvestment, weaken returns on growth, and make earnings more sensitive to costs, pricing, and product mix.
Weak Free-cash-flow ConversionVolatile free cash flow and very low conversion of net income reduce the quality and flexibility of SHK’s earnings. Limited cash generation can constrain internally funded expansion, dividends, or debt reduction, while increasing the importance of working-capital management and investment discipline.
Rising Debt And Lower ReturnsHigher debt alongside materially lower ROE suggests that the enlarged capital base is generating weaker economic returns. This combination can reduce capital-allocation efficiency and increase financial sensitivity if earnings remain subdued, particularly while cash-flow conversion is also weak.
S H Kelkar and Company Ltd News
SHK FAQ
What was S H Kelkar and Company Ltd’s price range in the past 12 months?
S H Kelkar and Company Ltd lowest stock price was ₹111.70 and its highest was ₹269.50 in the past 12 months.
What is S H Kelkar and Company Ltd’s market cap?
S H Kelkar and Company Ltd’s market cap is ₹20.97B.
When is S H Kelkar and Company Ltd’s upcoming earnings report date?
S H Kelkar and Company Ltd’s upcoming earnings report date is Nov 14, 2026 which is in 68 days.
How were S H Kelkar and Company Ltd’s earnings last quarter?
S H Kelkar and Company Ltd released its earnings results on Jul 28, 2026. The company reported ₹1.8 earnings per share for the quarter, beating the consensus estimate of ₹1 by ₹0.8.
Is S H Kelkar and Company Ltd overvalued?
According to Wall Street analysts S H Kelkar and Company Ltd’s price is currently Overvalued.
Does S H Kelkar and Company Ltd pay dividends?
S H Kelkar and Company Ltd pays a Semiannually dividend of ₹1 which represents an annual dividend yield of 1.32%. See more information on S H Kelkar and Company Ltd dividends here
What is S H Kelkar and Company Ltd’s EPS estimate?
S H Kelkar and Company Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does S H Kelkar and Company Ltd have?
S H Kelkar and Company Ltd has 138,420,800 shares outstanding.
What happened to S H Kelkar and Company Ltd’s price movement after its last earnings report?
S H Kelkar and Company Ltd reported an EPS of ₹1.8 in its last earnings report, beating expectations of ₹1. Following the earnings report the stock price went down -2.869%.
Which hedge fund is a major shareholder of S H Kelkar and Company Ltd?
Currently, no hedge funds are holding shares in IN:SHK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
S H Kelkar and Company Ltd
S H Kelkar and Company Limited, in conjunction with its subsidiary entities, functions as a principal producer and purveyor of aromatic compounds, flavorings, and various aroma ingredients, serving markets primarily in India and through exports. The company's fragrance offerings are incorporated into a broad spectrum of products, including those for personal hygiene, hair care, skin treatment, cosmetics, fabric conditioning, general household use, and high-end perfumes. Concurrently, its flavors are vital components in items such as dairy products, beverages, confectionery, baked goods, pharmaceuticals, nutraceuticals, and savory dishes. S H Kelkar markets its product lines through distinct brands like SHK, Cobra, and Keva, catering to a diverse customer base that spans major domestic and international Fast-Moving Consumer Goods (FMCG) corporations, alongside specialized blenders and manufacturers within the fragrance and flavor industries. The firm, established in 1914, is headquartered in Mumbai, India.
Technical Analysis
AVT Natural Products Limited
―
Camlin Fine Sciences Limited
―
Oriental Aromatics Ltd.
―
Privi Speciality Chemicals Limited
―
Rossari Biotech Ltd
―